XOVR Performance — ERShares Private-Public Crossover ETF
Data updated: 2026-09-10
XOVR returned +7.23% year to date and +12.62% over one year to Jun 2026. Annualised returns are +20.72% over 3 years and +5.27% over 5 years. The fund beat its Alternative category average: $100 invested three years ago grew to $176, against $170 for the category, and to $113 over one year, against $110. Volatility over the past three years was 21.70% a year. In the 12 months to Jun 2026 the fund took in a net $1.7B, and assets reached $2.19B.
XOVR Growth of $100
What $100 invested in ERShares Private-Public Crossover ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Alternative category average over the same months.
| Period | XOVR | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $113 | $110 |
| 3 years (Jul 2023 – Jun 2026) | $176 | $170 |
| 5 years (Jul 2021 – Jun 2026) | $129 | $159 |
| Since data start (Jan 2020 – Jun 2026) | $195 | $183 |
XOVR Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.23% |
| 1 year | +12.62% |
| 3 years (annualised) | +20.72% |
| 5 years (annualised) | +5.27% |
XOVR Annual Returns
Calendar-year total returns of ERShares Private-Public Crossover ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +7.23% |
| 2025 | +11.39% |
| 2024 | +33.33% |
| 2023 | +51.35% |
| 2022 | −40.53% |
| 2021 | −9.30% |
| 2020 | +50.38% |
XOVR Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −7.3% | −6.0% | −3.4% | +9.6% | +10.4% | +5.3% | — | — | — | — | — | — |
| 2025 | +5.3% | −7.4% | −9.3% | +3.1% | +8.4% | +7.2% | +3.0% | +1.4% | +5.8% | +1.0% | −7.3% | +1.4% |
| 2024 | −0.8% | +10.5% | +4.6% | −5.5% | +0.5% | +5.9% | −2.9% | +1.9% | +4.7% | +0.4% | +13.7% | −2.1% |
| 2023 | +15.5% | +0.6% | +6.3% | −3.2% | +8.1% | +6.1% | +4.7% | −5.0% | −5.4% | −4.4% | +11.9% | +9.8% |
| 2022 | −14.5% | −5.1% | +3.0% | −15.9% | −1.7% | −8.7% | +11.3% | −2.8% | −10.0% | +2.7% | +2.4% | −8.0% |
| 2021 | +2.4% | −0.7% | −9.2% | +3.0% | −3.3% | +9.3% | −2.6% | +4.2% | −7.4% | +8.6% | −6.7% | −5.3% |
| 2020 | +5.1% | −3.9% | −9.3% | +16.5% | +4.7% | +2.4% | +9.1% | +10.2% | −2.0% | −3.0% | +13.1% | +1.6% |
XOVR Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 21.70%
- 3-year Sharpe ratio: 0.75 (vs 4.5% risk-free rate)
- Best month: +13.66% (Nov 2024)
- Worst month: −9.28% (Mar 2025)
XOVR Fund Flows
Monthly money in and out of ERShares Private-Public Crossover ETF, from SEC Form N-PORT.
- 12-month net flow: $1.7B
- 12-month gross sales (incl. reinvestments): $4.6B
- Sales ÷ redemptions: 1.59×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $262.1M | $211.5M | $50.6M |
| May 2026 | $1.0B | $143.1M | $865.7M |
| Apr 2026 | $554.6M | $59.8M | $494.8M |
| Mar 2026 | $354.9M | $355.3M | −$376K |
| Feb 2026 | $330.2M | $1.3B | −$967.2M |
| Jan 2026 | $521.1M | $121.1M | $400.0M |
| Dec 2025 | $1.3B | $405.6M | $859.5M |
| Nov 2025 | $0 | $13.1M | −$13.1M |
| Oct 2025 | $88.1M | $157.0M | −$68.9M |
| Sep 2025 | $7.3M | $11.9M | −$4.6M |
| Aug 2025 | $0 | $19.4M | −$19.4M |
| Jul 2025 | $165.8M | $69.1M | $96.7M |
XOVR Assets Under Management
Net assets of ERShares Private-Public Crossover ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $2.19B |
| 2026-03-31 | $459.70M |
| 2025-12-31 | $1.26B |
| 2025-09-30 | $491.07M |
| 2025-06-30 | $371.23M |
| 2025-03-31 | $300.32M |
| 2024-12-31 | $205.67M |
| 2024-09-30 | $108.01M |
| 2024-06-30 | $84.78M |
| 2024-03-31 | $85.09M |
| 2023-12-31 | $72.88M |
| 2023-09-30 | $62.05M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.